Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast Cancer

Tissue-based next-generation sequencing (NGS) in metastatic breast cancer (mBC) is limited by the inability to noninvasively track tumor evolution. Cell-free DNA (cfDNA) NGS has made sequential testing feasible; however, the relationship between cfDNA and tissue-based testing in mBC is not well unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Minetta C., MacKay, Matthew, Kase, Matthew, Piwowarczyk, Aneta, Lo, Christine, Schaeffer, Jeff, Finkle, Justin D., Mason, Christopher E., Beaubier, Nike, Blackwell, Kimberly L., Park, Ben Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200387/
https://www.ncbi.nlm.nih.gov/pubmed/35721584
http://dx.doi.org/10.1200/PO.21.00321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200387/
https://www.ncbi.nlm.nih.gov/pubmed/35721584
http://dx.doi.org/10.1200/PO.21.00321

Ejemplares similares